🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
SOB
$SOBI.ST
🔒 EuropeSwedish Orphan Biovitrum AB
AVG HISTORICAL GAP
+1.57%
MAX GAP RECORD
-8.73%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $SOBI.ST
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$SOBI.ST
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 27, 2026 Earnings Release 2026-10-27 (AFTER CLOSE (16:00)) |
+3.02%
|
| Jul 16, 2026 Earnings Release 2026-07-16 (BEFORE OPEN) |
+4.39%
|
| Apr 28, 2026 Earnings Release 2026-04-28 (BEFORE OPEN) |
+2.86%
|
| Feb 05, 2026 Earnings Release 2026-02-05 (BEFORE OPEN) |
+2.85%
|
| Oct 20, 2025 Earnings Release 2025-10-20 (BEFORE OPEN) |
+2.57%
|
| Jul 16, 2025 Earnings Release 2025-07-16 (BEFORE OPEN) |
+2.11%
|
| Apr 29, 2025 Earnings Release 2025-04-29 (BEFORE OPEN) |
-0.86%
|
| Feb 05, 2025 Earnings Release 2025-02-05 (BEFORE OPEN) |
-2.13%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.4%
Bullish Gaps (11)
Bearish Gaps (3)
Neutral / Flat (1)
📖 Intelligence Summary
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. It operates through the Haematology, Immunology, and Specialty Care segments. The Haemotology segment focuses on haemophilia medicines Elocta and Alprolix. The immunology segment offers treatment for serious, disabling, and life-threatening diseases. The Specialty Care segment specializes…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗